TC
NPTN

Truvestments Capital’s NEOPHOTONICS CORP NPTN Stock Holding History

Truvestments Capital’s Portfolio NPTN Stock Details NPTN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-10,578
Closed -$166K – 671
2022
Q2 		$166K Sell
10,578
-870
-8% -$13.3K 0.1% 172
2022
Q1 		$174K Sell
11,448
-191
-2% -$2.91K 0.1% 175
2021
Q4 		$179K Buy
11,639
+1,305
+13% +$17.2K 0.09% 170
2021
Q3 		$90K Buy
10,334
+496
+5% +$4.52K 0.05% 212
2021
Q2 		$100K Buy
9,838
+1,434
+17% +$15.1K 0.05% 198
2021
Q1 		$100K Buy
8,404
+4,075
+94% +$46.2K 0.06% 210
2020
Q4 		$39K Buy
+4,329
New +$33.5K 0.03% 293
2020
Q3 		– Sell
-2,650
Closed -$23K – 596
2020
Q2 		$23K Buy
2,650
+1,526
+136% +$13.2K 0.02% 289
2020
Q1 		$8K Buy
+1,124
New +$8.33K 0.01% 381
2019
Q4 		– Sell
-1,857
Closed -$11K – 656
2019
Q3 		$11K Sell
1,857
-274
-13% -$1.54K 0.01% 488
2019
Q2 		$9K Hold
2,131
– – 0.01% 546
2019
Q1 		$13K Buy
+2,131
New +$14.9K 0.01% 484
2018
Q3 		$17K Buy
+2,044
New +$15.5K 0.01% 549

Other funds holding NPTN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Truvestments Capital's NPTN Position: Q3 2022 in Review

Truvestments Capital sold out of NEOPHOTONICS CORP (NPTN) in Q3 2022, closing a stake of 10,578 shares — an estimated $166K sold.

Truvestments Capital first reported a position in NPTN in Q3 2018 and held it in 13 quarters. The position peaked at $179K in Q4 2021. 2 funds tracked by Wall St. Rank hold NPTN as of Q3 2022.

  • Truvestments Capital reported no remaining NEOPHOTONICS CORP position as of Q3 2022 after selling out during the quarter.
  • Truvestments Capital sold 10,578 NEOPHOTONICS CORP shares in Q3 2022, an estimated $166K.
  • Truvestments Capital first reported a position in NEOPHOTONICS CORP in Q3 2018 and held it in 13 quarters.
  • Truvestments Capital's NEOPHOTONICS CORP position peaked at $179K in Q4 2021.
  • 2 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q3 2022.

Based on Truvestments Capital's 13F filing for Q3 2022, filed 15 Nov 2022.